Last updated on June 2019

A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders


Brief description of study

This study is a phase II of effcicacy and tolerance of azacitidine in patients with myelodysplatic syndrome and steroid dependent or resistent systemic auto-immune and inflammatory disorders

Detailed Study Description

This trial will be a prospective French nationwide study analyzing the effect of treatment with azacitidine in patients with MDS-associated SAID with steroid dependence and/or resistance, and its correlation with possible changes in immunological parameters

Clinical Study Identifier: NCT02985190

Find a site near you

Start Over

CHU Amiens

Amiens cedex 01, France
  Connect »

CH Valence

Valence, France
  Connect »

CHR d'Orl ans

Orléans, France
  Connect »

H pital Archet 1

Nice cedex 3, France
  Connect »

CH Yves Le Foll

Saint-Brieuc, France
  Connect »

CH Ren Dubos

Cergy-Pontoise, France
  Connect »

CHU d'Angers

Angers cedex 9, France
  Connect »

CHU Estaing

Clermont-Ferrand, France
  Connect »

CHSF Gilles de Corbeil

Corbeil-Essonnes, France
  Connect »

CHU de Grenoble

Grenoble cedex 09, France
  Connect »

CH Le Mans

Le Mans cedex 09, France
  Connect »

CH de Mont de Marsan

Mont-de-Marsan, France
  Connect »

CHU de N mes

Nîmes cedex 9, France
  Connect »

CHR d'Orl ans

Orléans, France
  Connect »

IUCT Oncopole

Toulouse, France
  Connect »

CHU Brabois

Vandoeuvre-les-Nancy, France
  Connect »

CHU de N mes

Nîmes cedex 9, France
  Connect »

CHR d'Orl ans

Orléans, France
  Connect »